I was told a week ago at my MS Clinic.... that we have to remember these are early data that the FDA approved the drug on.As part of the approval, the manufacturer has committed to continuing its trials of this product for another year. 66% WOW
Further testing still needs to be done...on the CRAB's and Antigren/Tysabri. Also the Avonex Antegren study is still going on for another year in some clinic's.
I was also told it will be an infusion that will cost 20,000. What about our Caps?? I do think this is what we have all been waiting for. My specialist told me in Europe they only did studys on Antegren alone.
I would like to know about the percent of heart attacks that were caused by the drug. I was told this is why this has to be given in a hospital setting because of the risk...although slight... of antaphalactic shock. This is my question.
Also I was told they only pretty much chose progressing RR patients for these trials. Good to talk..been awhile...Kim